Published in PLoS One on August 26, 2013
Warfarin dosage response related pharmacogenetics in Chinese population. PLoS One (2015) 0.90
A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients. PLoS One (2014) 0.87
A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy. Int J Mol Sci (2015) 0.82
Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacement. PLoS One (2014) 0.77
Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement. Medicine (Baltimore) (2017) 0.75
The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study. PLoS One (2016) 0.75
Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients. Biomed Rep (2016) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (2004) 21.39
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal (1999) 9.80
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res (2000) 5.24
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood (2004) 4.70
Identification of the gene for vitamin K epoxide reductase. Nature (2004) 4.52
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
CYP4F2 genetic variant alters required warfarin dose. Blood (2008) 4.23
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol (2012) 2.76
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis (2007) 2.12
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms. Eur J Clin Pharmacol (2012) 2.07
CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet Med (2005) 2.06
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol (2009) 1.92
Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans. Pharmacogenomics (2008) 1.89
Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics (2010) 1.82
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood (2011) 1.77
Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery. Am J Health Syst Pharm (2009) 1.60
Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol (2011) 1.43
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. Pharmacogenomics (2009) 1.32
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. Br J Clin Pharmacol (2012) 1.28
Pharmacogenetics of warfarin. Annu Rev Med (2010) 1.25
Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement--a systematic review and meta analysis. Thromb Res (2009) 1.15
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. Pharmacogenomics (2011) 1.14
A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity. J Clin Pharmacol (2009) 1.10
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians. Pharmacogenomics (2007) 1.05
Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis. Thromb Res (2011) 1.05
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis. Clin Pharmacol Ther (2012) 1.00
Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements. J Hum Genet (2010) 0.98
Optimization of warfarin dose by population-specific pharmacogenomic algorithm. Pharmacogenomics J (2011) 0.98
Warfarin versus new agents: interpreting the data. Hematology Am Soc Hematol Educ Program (2010) 0.91
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal. Pharmacogenomics (2009) 0.86
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction. J Biomed Biotechnol (2010) 0.86
Pharmacoeconomic evaluation of warfarin pharmacogenomics. Expert Opin Pharmacother (2011) 0.86
Overview of pharmacogenetics in anticoagulation therapy. Clin Lab Med (2008) 0.86
Population diversity and the performance of warfarin dosing algorithms. Br J Clin Pharmacol (2011) 0.86
Dynamic pharmacogenetic models in anticoagulation therapy. Clin Lab Med (2008) 0.84
Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance. Clin Proteomics (2011) 0.83
Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses. Clin Med Res (2011) 0.80
Clinical applications of pharmacogenomics guided warfarin dosing. Int J Clin Pharm (2011) 0.78
Old versus new oral anticoagulants: focus on pharmacology. Annu Rev Pharmacol Toxicol (2011) 0.78
Genetic variations and their influence on risk and treatment of venous thrombosis. Pharmacogenomics (2008) 0.78
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin. J Clin Pharm Ther (2011) 0.77
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J (2005) 3.07
VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). Eur Heart J (2003) 2.05
Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke (2002) 1.93
Oxidative stress effects on endothelial cells treated with different athletes' sera. Med Sci Sports Exerc (2012) 1.62
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation (2009) 1.62
Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J Neurosci (2012) 1.55
TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol (2012) 1.55
miR-519d overexpression is associated with human obesity. Obesity (Silver Spring) (2010) 1.54
Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome. Intensive Care Med (2006) 1.49
Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Med (2004) 1.45
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. Eur J Neurosci (2011) 1.45
Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr (2011) 1.41
Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res (2008) 1.40
Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL/6J, 129SV/EV and C3H/HeJ Mouse Strains. PLoS One (2008) 1.19
HLA related genetic risk for coeliac disease. Gut (2007) 1.16
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. Cardiovasc Res (2007) 1.15
Aerobic training workload affects human endothelial cells redox homeostasis. Med Sci Sports Exerc (2013) 1.14
Exercise training in aging and diseases. Transl Med UniSa (2012) 1.11
Disability and 6-year mortality in elderly population. Role of visual impairment. Aging Clin Exp Res (2004) 1.10
Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am J Physiol Heart Circ Physiol (2010) 1.06
An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol (2013) 1.06
miRNA and protein expression profiles of visceral adipose tissue reveal miR-141/YWHAG and miR-520e/RAB11A as two potential miRNA/protein target pairs associated with severe obesity. J Proteome Res (2012) 1.04
High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) (2010) 1.04
Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss. Clin Chem (2004) 1.01
Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost (2004) 0.99
Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. PLoS One (2008) 0.98
Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res (2004) 0.98
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Mol Pharmacol (2010) 0.98
Connectivity between posterior parietal cortex and ipsilateral motor cortex is altered in schizophrenia. Biol Psychiatry (2008) 0.97
Is physical activity able to modify oxidative damage in cardiovascular aging? Oxid Med Cell Longev (2012) 0.96
Adrenoreceptors and nitric oxide in the cardiovascular system. Front Physiol (2013) 0.95
MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One (2011) 0.95
Role of sirtuins, calorie restriction and physical activity in aging. Front Biosci (Elite Ed) (2012) 0.95
Prevalence and long-term course of macro-aspartate aminotransferase in children. J Pediatr (2008) 0.95
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia. Am J Hematol (2012) 0.94
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology (2010) 0.94
Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am J Cardiol (2005) 0.94
Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J Interferon Cytokine Res (2008) 0.93
F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma. Eur J Haematol (2014) 0.93
Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients. Eur J Clin Pharmacol (2011) 0.93
Adrenergic signaling and oxidative stress: a role for sirtuins? Front Physiol (2013) 0.93
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Cardiovasc Prev Rehabil (2008) 0.92
Hypermagnesemia predicts mortality in elderly with congestive heart disease: relationship with laxative and antacid use. Rejuvenation Res (2008) 0.91
[Sulphur mineral water and SPA therapy in osteoarthritis]. Therapie (2012) 0.91
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey. Leuk Lymphoma (2013) 0.91
Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation. Am J Physiol Heart Circ Physiol (2007) 0.90
Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 0.90
Exercise training affects age-induced changes in SOD and heat shock protein expression in rat heart. Exp Gerontol (2006) 0.89
Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy. PLoS One (2012) 0.89
Radical-trapping activity, blood pressure, and carotid enlargement in women. Hypertension (2003) 0.88
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci (2010) 0.87
Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy. Clin Chem (2005) 0.86
Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur J Pharmacol (2007) 0.86
A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clin Chem (2006) 0.86
Aging-related changes in oxidative stress response of human endothelial cells. Aging Clin Exp Res (2015) 0.85
Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. Eur J Pharm Biopharm (2008) 0.85
A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. Atherosclerosis (2003) 0.85
High aminopeptidase N/CD13 levels characterize human amniotic mesenchymal stem cells and drive their increased adipogenic potential in obese women. Stem Cells Dev (2013) 0.84
Improving the estimation of celiac disease sibling risk by non-HLA genes. PLoS One (2011) 0.84
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84
Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J Hypertens (2003) 0.84
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery. Br J Pharmacol (2006) 0.84
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle. J Biol Chem (2002) 0.83
Direct detection of exon deletions/duplications in female carriers of and male patients with Duchenne/Becker muscular dystrophy. Clin Chem (2004) 0.83
Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy. Gene (2010) 0.83
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases. Mediterr J Hematol Infect Dis (2012) 0.81
The mtDNA 15497 G/A polymorphism in cytochrome b in severe obese subjects from Southern Italy. Nutr Metab Cardiovasc Dis (2005) 0.81
Haplogroup T is an obesity risk factor: mitochondrial DNA haplotyping in a morbid obese population from southern Italy. Biomed Res Int (2013) 0.81
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. Liver Int (2008) 0.81
Mitochondrial diabetes in children: seek and you will find it. PLoS One (2012) 0.81
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology (2008) 0.81
Memantine-induced hepatitis with cholestasis in a very elderly patient. Ann Intern Med (2008) 0.81
Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction. Invest New Drugs (2009) 0.80
Sequence Analysis of the UCP1 Gene in a Severe Obese Population from Southern Italy. J Obes (2011) 0.80
Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion. Pacing Clin Electrophysiol (2005) 0.80
Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander? Am J Blood Res (2013) 0.80
Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women. Am J Clin Nutr (2002) 0.79
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes. Strahlenther Onkol (2014) 0.79
Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production. Br J Pharmacol (2004) 0.79
Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Ann Nutr Metab (2008) 0.79
Adaptations of striatal endocannabinoid system during stress. Mol Neurobiol (2009) 0.79
Increased carotid artery intima-media thickness is associated with a novel mutation of low-density lipoprotein receptor independently of major cardiovascular risk factors. Metabolism (2003) 0.79
Specificity of atrial mode switching in detecting atrial fibrillation episodes: roles of length and contiguity. Pacing Clin Electrophysiol (2005) 0.78
Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases. Curr Drug Targets (2017) 0.78
Efficacy of transdermal nitroglycerin patches evaluated by dipyridamole-induced myocardial ischemia in patients with coronary artery disease. Comparison between continuous and intermittent schedule. Cardiovasc Drugs Ther (2002) 0.78
A Polysaccharide from tomato (Lycopersicon esculentum) peels affects NF-kappaB activation in LPS-stimulated J774 macrophages. J Nat Prod (2007) 0.78
Catechol-O-methyltransferase (COMT) gene polymorphisms as risk factor in temporomandibular disorders patients from Southern Italy. Clin J Pain (2014) 0.78
Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF). PLoS One (2013) 0.78